The Society for Immunotherapy of Cancer (SITC) hosted "Session 304: Phase-Dependent Regulatory Considerations in Manufacturing of Cellular Therapy Products" during the 36th Annual Meeting & Pre-Conference Programs on November 13, 2021. Available here are the presentation slides and video from the session, as permitted by presenters.
36th Annual Meeting Organizers
Annual Program Committee
Session Co-Chairs:
To view the entire program schedule (including presenter permission to post) please click here.
Program: SITC 36th Annual Meeting: Sunday Sessions; Session 304: Phase-Dependent Regulatory Considerations in Manufacturing of Cellular Therapy Products; Presenter: Kimberly Schultz, PhD – Food and Drug Administration; Date: November 14, 202100:19:35
Program: SITC 36th Annual Meeting: Sunday Sessions; Session 304: Phase-Dependent Regulatory Considerations in Manufacturing of Cellular Therapy Products; Presenter: Matthew Klinker, PhD – Food and Drug Administration; Date: November 14, 202100:25:34